Skip to content
2000
Volume 24, Issue 1
  • ISSN: 2211-3525
  • E-ISSN: 2211-3533

Abstract

The 21st century has witnessed a dramatic surge in dengue pandemics, establishing it as a major global health concern. Dengue is a debilitating viral disease caused by the dengue virus, a member of the Flaviviridae family. Transmission primarily occurs through the bite of infected female mosquitoes, particularly . The global incidence of dengue has increased dramatically in recent decades, with an estimated 390 million infections occurring annually. Clinical manifestations of dengue vary widely, ranging from mild febrile illness to severe dengue, which can be life-threatening. Despite extensive research efforts, no specific antiviral therapy for dengue exists, underscoring the critical importance of early and accurate diagnosis for effective management and mortality reduction. However, the lack of widely available and reliable diagnostic tools, particularly in resource-limited settings, poses a significant challenge. This comprehensive review provides an in-depth overview of dengue, encompassing its virology, pathogenesis, clinical presentation, and the latest advancements in diagnostic techniques. We delve into both conventional methods, such as serological and molecular tests, and emerging diagnostic approaches. Furthermore, we discuss current management strategies for dengue, including supportive care, vector control measures, and ongoing efforts in vaccine development. In conclusion, effectively combating dengue necessitates a multifaceted approach involving continuous research and development of innovative diagnostic tools, effective antiviral therapies, and the realization of a safe and effective vaccine.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/aia/10.2174/0122113525366277250306072415
2025-03-19
2026-03-09

  • From This Site

    /content/journals/aia/10.2174/0122113525366277250306072415
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Paz-BaileyG. AdamsL.E. DeenJ. AndersonK.B. KatzelnickL.C. Dengue.Lancet20244031042766768210.1016/S0140‑6736(23)02576‑X 38280388
     [Google Scholar]
  2. CeciliaD. Current status of dengue and chikungunya in India.WHO South-East Asia J. Public Health2014312226 https://pubmed.ncbi.nlm.nih.gov/28607250/ 28607250
     [Google Scholar]
  3. MandodanS. KunnikuruvanA. BoraB. PadmanabanH. VijayakumarA. GangmeiK. SivaprakasamM. LukoseJ. AshokkumarM. KrishnamoorthyV. PoopathiS. Applications of nanomaterials in mosquito vector control: A review.Asian Pac. J. Trop. Med.2023161147948910.4103/1995‑7645.390164
     [Google Scholar]
  4. BeckhamJ.D. TylerK.L. Arbovirus infections.Continuum20152161599161110.1212/CON.0000000000000240 26633778
     [Google Scholar]
  5. TayalA. KabraS.K. LodhaR. Management of dengue: An updated review.Indian J. Pediatr.202390216817710.1007/s12098‑022‑04394‑8 36574088
     [Google Scholar]
  6. YangX. QuamM.B.M. ZhangT. SangS. Global burden for dengue and the evolving pattern in the past 30 years.J. Travel Med.2021288taab14610.1093/jtm/taab146 34510205
     [Google Scholar]
  7. MalavigeG.N. SjöP. SinghK. PiedagnelJ.M. MowbrayC. EstaniS. LimS.C.L. SiquierraA.M. OggG.S. FraisseL. RibeiroI. Facing the escalating burden of dengue: Challenges and perspectives.PLOS Glob. Public Health2023312e000259810.1371/journal.pgph.0002598 38100392
     [Google Scholar]
  8. LiangY. DaiX. The global incidence and trends of three common flavivirus infections (Dengue, yellow fever, and Zika) from 2011 to 2021.Front. Microbiol.202415145816610.3389/fmicb.2024.1458166 39206366
     [Google Scholar]
  9. InduP.S. AnishT.S. ChinthaS. LibuG.K. TonyL. SijuN.S. SreekumarE. SanthoshkumarA. AravindR. SaradadeviK.L. SunijaS. JohnsonJ. AnupriyaM.G. MathewT. ReenaK.J. MeenakshyV. NamithaP. KumarN.P. KumariR. MohamedA.J. NagpalB. SarkarS. SadanandanR. VelayudhanR. The burden of dengue and force of infection among children in Kerala, India; seroprevalence estimates from Government of Kerala-WHO Dengue study.Lancet Reg. Health Southeast Asia20242210033710.1016/j.lansea.2023.100337 38482148
     [Google Scholar]
  10. ShengZ.Y. LiM. YangR. LiuY.H. YinX.X. MaoJ.R. BrownH.E. AnJ. ZhouH.N. WangP.G. COVID-19 prevention measures reduce dengue spread in Yunnan Province, China, but do not reduce established outbreak.Emerg. Microbes Infect.202211124024910.1080/22221751.2021.2022438 34935597
     [Google Scholar]
  11. HadinegoroS.R.S. The revised WHO dengue case classification: Does the system need to be modified?Paediatr. Int. Child Health201232Suppl. 13338
     [Google Scholar]
  12. RossT.M. Dengue virus.Clin. Lab. Med.201030114916010.1016/j.cll.2009.10.007 20513545
     [Google Scholar]
  13. SiddquiG. VishwakarmaP. SaxenaS. KumarV. BajpaiS. KumarA. KumarS. KhatriR. KaurJ. BhattacharyaS. AhmedS. SyedG.H. KumarY. SamalS. Aged AG129 mice support the generation of highly virulent novel mouse-adapted DENV (1-4) viruses exhibiting neuropathogenesis and high lethality.Virus Res.202434119933110.1016/j.virusres.2024.199331 38280436
     [Google Scholar]
  14. MustafaM.S. RasotgiV. JainS. GuptaV. Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control.Med. J. Armed Forces India2015711677010.1016/j.mjafi.2014.09.011 25609867
     [Google Scholar]
  15. ArshadM. QamarA.M. MissenM.M.S. LodhiA.A. PrasathV.B.S. Global trends and collaborations in dengue virus research: A scientometric and bibliometric overview (1872–2019).Int. J. Des. Nat. Ecodyn.20231861539154810.18280/ijdne.180630
     [Google Scholar]
  16. YuX. ChengG. Contribution of phylogenetics to understanding the evolution and epidemiology of dengue virus.Animal Model. Exp. Med.20225541041710.1002/ame2.12283 36245335
     [Google Scholar]
  17. GanV.C. Dengue: Moving from current standard of care to state-of-the-art treatment.Curr. Treat. Options Infect. Dis.20146320822610.1007/s40506‑014‑0025‑1 25999799
     [Google Scholar]
  18. WangE. NiH. XuR. BarrettA.D.T. WatowichS.J. GublerD.J. WeaverS.C. Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses.J. Virol.20007473227323410.1128/JVI.74.7.3227‑3234.2000 10708439
     [Google Scholar]
  19. GuptaN. SrivastavaS. JainA. ChaturvediU.C. Dengue in India.Indian J. Med. Res.20121363373390 23041731
     [Google Scholar]
  20. De La GuardiaC. LleonartR. Progress in the identification of dengue virus entry/fusion inhibitors.BioMed Res. Int.20142014111310.1155/2014/825039 25157370
     [Google Scholar]
  21. SubramaniyanV. VenkatachalamR. SrinivasanP. PalaniM. In silico prediction of monovalent and chimeric tetravalent vaccines for prevention and treatment of dengue fever.J. Biomed. Res.2017323222236 29497025
     [Google Scholar]
  22. KawadaH. TakemuraS.Y. ArikawaK. TakagiM. Comparative study on nocturnal behavior of Aedes aegypti and Aedes albopictus.J. Med. Entomol.200542331231810.1093/jmedent/42.3.312 15962780
     [Google Scholar]
  23. RuizJ. The Emergence of Aedes Aegypti in California: Implications for Ecosystems and Public Health; B.A. Thesis, Claremont McKenna College,2024Available from: https://scholarship.claremont.edu/cmc_theses/3528/
  24. DelrieuM. MartinetJ.P. O’ConnorO. ViennetE. MenkesC. Burtet-SarramegnaV. FrentiuF.D. Dupont-RouzeyrolM. Temperature and transmission of chikungunya, dengue, and zika viruses: A systematic review of experimental studies on Aedes aegypti and Aedes albopictus.Curr. Res. Parasitol. Vector Borne Dis.2023410013910.1016/j.crpvbd.2023.100139 37719233
     [Google Scholar]
  25. BeatyB. BernhardtS. BlackW. BlairC. EisenL. Elizondo-QuirogaD. Farfan-AleJ. Lozano-FuentesS. FranzA. OlsonK.E. Sanchez-VargasI. Novel strategies to control Aedes aegypti and dengue. Vector Biology, Ecology and Control.DordrechtSpringer20109911110.1007/978‑90‑481‑2458‑9_7
     [Google Scholar]
  26. WeeratungaP. RodrigoC. FernandoS.D. RajapakseS. Control methods for Aedes albopictus and Aedes aegypti.Cochrane Database Syst. Rev.201720178CD012759
     [Google Scholar]
  27. OliveiraA.F.C.S. TeixeiraR.R. OliveiraA.S. SouzaA.P.M. SilvaM.L. PaulaS.O. Potential antivirals: Natural products targeting replication enzymes of dengue and chikungunya viruses.Molecules201722350510.3390/molecules22030505 28327521
     [Google Scholar]
  28. TeixeiraR. PereiraW. OliveiraA. Da SilvaA. De OliveiraA. Da SilvaM. Da SilvaC. De PaulaS. Natural products as source of potential dengue antivirals.Molecules20141968151817610.3390/molecules19068151 24941340
     [Google Scholar]
  29. Cruz-OliveiraC. FreireJ.M. ConceiçãoT.M. HigaL.M. CastanhoM.A.R.B. Da PoianA.T. Receptors and routes of dengue virus entry into the host cells.FEMS Microbiol. Rev.201539215517010.1093/femsre/fuu004 25725010
     [Google Scholar]
  30. BhattP. SabeenaS.P. VarmaM. ArunkumarG. Current understanding of the pathogenesis of dengue virus infection.Curr. Microbiol.2021781173210.1007/s00284‑020‑02284‑w 33231723
     [Google Scholar]
  31. KayeshM.E.H. KoharaM. Tsukiyama-KoharaK. Recent insights into the molecular mechanism of toll-like receptor response to dengue virus infection.Front. Microbiol.20211274423310.3389/fmicb.2021.744233 34603272
     [Google Scholar]
  32. IdreesS. AshfaqU.A. RNAi: Antiviral therapy against dengue virus.Asian Pac. J. Trop. Biomed.20133323223610.1016/S2221‑1691(13)60057‑X 23620845
     [Google Scholar]
  33. HtunT.P. XiongZ. PangJ. Clinical signs and symptoms associated with WHO severe dengue classification: A systematic review and meta-analysis.Emerg. Microbes Infect.20211011116112810.1080/22221751.2021.1935327 34036893
     [Google Scholar]
  34. GweeS.X.W. St JohnA.L. GrayG.C. PangJ. Animals as potential reservoirs for dengue transmission: A systematic review.One Health20211210021610.1016/j.onehlt.2021.100216 33598525
     [Google Scholar]
  35. IslamM.T. QuispeC. Herrera-BravoJ. SarkarC. SharmaR. GargN. FredesL.I. MartorellM. AlshehriM.M. Sharifi-RadJ. DaştanS.D. CalinaD. AlsafiR. AlghamdiS. BatihaG.E.S. Cruz-MartinsN. Production, transmission, pathogenesis, and control of dengue virus: A literature-based undivided perspective.BioMed Res. Int.202120211422481610.1155/2021/4224816 34957305
     [Google Scholar]
  36. NimmoD. Aedes aegypti and Aedes albopictus: Life Cycle, Biology and Distribution; Oxitec Limited Confidential Document,2015Available from: https://www.genewatch.org/uploads/f03c6d66a9b354535738483c1c3d49e4/appen_4__doc_4.pdf.
  37. FacchinelliL. BadoloA. McCallP.J. Biology and behaviour of Aedes aegypti in the human environment: Opportunities for vector control of arbovirus transmission.Viruses202315363610.3390/v15030636 36992346
     [Google Scholar]
  38. GuzmanM.G. GublerD.J. IzquierdoA. MartinezE. HalsteadS.B. Dengue infection.Nat. Rev. Dis. Primers2016211605510.1038/nrdp.2016.55 27534439
     [Google Scholar]
  39. LeowattanaW. LeowattanaT. Dengue hemorrhagic fever and the liver.World J. Hepatol.202113121968197610.4254/wjh.v13.i12.1968 35070001
     [Google Scholar]
  40. LeeI.K. LeeN.Y. HuangW.C. HsuJ.C. TaiC.H. YangC.H. HuangC.H. LinC.Y. ChangK. ChenY.H. In-hospital mortality predictors among hospitalized adults and those with chronic kidney disease with dengue.J. Microbiol. Immunol. Infect.2023565996100610.1016/j.jmii.2023.08.004 37604758
     [Google Scholar]
  41. ZerfuB. KassaT. LegesseM. Epidemiology, biology, pathogenesis, clinical manifestations, and diagnosis of dengue virus infection, and its trend in Ethiopia: A comprehensive literature review.Trop. Med. Health20235111110.1186/s41182‑023‑00504‑0 36829222
     [Google Scholar]
  42. BeesettiH. KhannaN. SwaminathanS. Drugs for dengue: A patent review (2010 – 2014).Expert Opin. Ther. Pat.201424111171118410.1517/13543776.2014.967212 25283170
     [Google Scholar]
  43. LukmanN. SalimG. KosasihH. SusantoN.H. ParwatiI. FitriS. AlisjahbanaB. WidjajaS. WilliamsM. Comparison of the hemagglutination inhibition test and IgG ELISA in categorizing primary and secondary dengue infections based on the plaque reduction neutralization test.BioMed Res. Int.2016201611510.1155/2016/5253842 27446953
     [Google Scholar]
  44. TripathiA. BanerjeeA. VratiS. Development and characterization of an animal model of Japanese encephalitis virus infection in adolescent C57BL/6 mouse.Dis. Model. Mech.20211410dmm04917610.1242/dmm.049176 34447981
     [Google Scholar]
  45. LimaM.R.Q. NunesP.C.G. dos SantosF.B. Serological diagnosis of dengue.Methods Mol. Biol.2022240917319610.1007/978‑1‑0716‑1879‑0_12
     [Google Scholar]
  46. De PaulaS.O. FonsecaB.A.L. Dengue: A review of the laboratory tests a clinician must know to achieve a correct diagnosis.Braz. J. Infect. Dis.20048639039810.1590/S1413‑86702004000600002 15880229
     [Google Scholar]
  47. TsaiJ.J. TsaiC.Y. LinP.C. ChenC.H. TsaiW.Y. DaiY.C. LinY.C. PedrosoC. BritesC. WangW.K. Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study.BMC Infect. Dis.202323130110.1186/s12879‑023‑08307‑8 37158835
     [Google Scholar]
  48. MedinaF.A. VilaF. PremkumarL. LorenziO. Paz-BaileyG. AlvaradoL.I. Rivera-AmillV. de SilvaA. WatermanS. Muñoz-JordánJ. Capacity of a multiplex IgM antibody capture ELISA to differentiate zika and dengue virus infections in areas of concurrent endemic transmission.Am. J. Trop. Med. Hyg.2022106258559210.4269/ajtmh.20‑1651 34929668
     [Google Scholar]
  49. Alcon-LePoderS. DrouetM.T. RouxP. FrenkielM.P. ArborioM. Durand-SchneiderA.M. MauriceM. Le BlancI. GruenbergJ. FlamandM. The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: Implications for viral infectivity.J. Virol.20057917114031141110.1128/JVI.79.17.11403‑11411.2005 16103191
     [Google Scholar]
  50. KassimF.M. IzatiM.N. TgRogayahT.A. ApandiY.M. SaatZ. Use of dengue NS1 antigen for early diagnosis of dengue virus infection.Southeast Asian J. Trop. Med. Public Health2011423562569 21706934
     [Google Scholar]
  51. AntunesP. WattersonD. ParmviM. BurgerR. BoisenA. YoungP. CooperM.A. HansenM.F. RanzoniA. DonolatoM. Quantification of NS1 dengue biomarker in serum via optomagnetic nanocluster detection.Sci. Rep.2015511614510.1038/srep16145 26536916
     [Google Scholar]
  52. KabirM.A. ZilouchianH. YounasM.A. AsgharW. Dengue detection: Advances in diagnostic tools from conventional technology to point of care.Biosensors202111720610.3390/bios11070206 34201849
     [Google Scholar]
  53. GhoshP. SahaB. KaveriK. TripathiA. 2025. Significance of diagnostic and therapeutic potential of serum endothelial and inflammatory biomarkers in defining disease severity of dengue infected patients.Med. Microbiol. Immunol.20252141310.1007/s00430‑024‑00810‑2
     [Google Scholar]
  54. BalasaravananK PrakashM Detection of dengue disease using artificial neural network based classification technique.Int. J. Eng. Technol.201871.3135
     [Google Scholar]
  55. HegdeS.S. BhatB.R. Dengue detection: Advances and challenges in diagnostic technology.Biosens. Bioelectron. X20221010010010.1016/j.biosx.2021.100100
     [Google Scholar]
  56. Eivazzadeh-KeihanR. Pashazadeh-PanahiP. MahmoudiT. ChenabK.K. BaradaranB. HashemzaeiM. RadinekiyanF. MokhtarzadehA. MalekiA. Dengue virus: A review on advances in detection and trends – From conventional methods to novel biosensors.Mikrochim. Acta2019186632910.1007/s00604‑019‑3420‑y 31055654
     [Google Scholar]
  57. ParkashO. AbdullahM.A. YeanC.Y. SekaranS.D. ShuebR.H. Development and evaluation of an electrochemical biosensor for detection of dengue-specific IGM antibody in serum samples.Diagnostics20201113310.3390/diagnostics11010033 33375384
     [Google Scholar]
  58. HegdeS.S. Shivakumar BhatB.R. MishraP. DalimbaU. AhmedM.U. SantosG.N. A novel and ultrasensitive high-surface porous carbon-based electrochemical biosensor for early detection of dengue virus.Biosens. Bioelectron. X20242010052510.1016/j.biosx.2024.100525
     [Google Scholar]
  59. NasrinF. TsurugaK. UtomoD.I.S. ChowdhuryA.D. ParkE.Y. Design and analysis of a single system of impedimetric biosensors for the detection of mosquito-borne viruses.Biosensors2021111037610.3390/bios11100376 34677332
     [Google Scholar]
  60. SanthanamK.S.V. Electrochemical approaches towards sensing viruses: A mini review.Med. Devices Sens.202141e1014810.1002/mds3.10148
     [Google Scholar]
  61. SharmaS. KumarA. Design of a biosensor for the detection of dengue virus using 1D photonic crystals.Plasmonics202217267568010.1007/s11468‑021‑01555‑x
     [Google Scholar]
  62. KattaM. SandanalakshmiR. Simultaneous tropical disease identification with PZT-5H piezoelectric material including molecular mass biosensor microcantilever collection.Sens. Biosensing Res.20213210041310.1016/j.sbsr.2021.100413
     [Google Scholar]
  63. JiangK. LeeJ.H. FungT.S. WuJ. LiuC. MiH. RajapakseR.P.V.J. BalasuriyaU.B.R. PengY.K. GoY.Y. Next-generation diagnostic test for dengue virus detection using an ultrafast plasmonic colorimetric RT-PCR strategy.Anal. Chim. Acta2023127434156510.1016/j.aca.2023.341565 37455070
     [Google Scholar]
  64. IqbalK. HashmiA.S. IdreesM. ShahzadS. FatimaZ. Polymerase chain reaction-based detection method is suitable for dengue infection during epidemics.Viral Immunol.2017301073473610.1089/vim.2017.0057 28949818
     [Google Scholar]
  65. SharmaB. SharmaA. Microfluidics: Recent advances toward lab-on-chip applications in bioanalysis.Adv. Eng. Mater.2022242210073810.1002/adem.202100738
     [Google Scholar]
  66. CunhaM.L. da SilvaS.S. StrackeM.C. ZanetteD.L. AokiM.N. BlanesL. Sample preparation for lab-on-a-chip systems in molecular diagnosis: A review.Anal. Chem.2022941415810.1021/acs.analchem.1c04460 34870427
     [Google Scholar]
  67. HoangT.X. PhanL.M.T. VoT.A.T. ChoS. Advanced signal-amplification strategies for paper-based analytical devices: A comprehensive review.Biomedicines20219554010.3390/biomedicines9050540 34066112
     [Google Scholar]
  68. ChenC. TianL. LiW. WangK. YangQ. LinJ. ZhangT. DongB. WangL. Recent advances and perspectives regarding paper-based sensors for salivary biomarker detection.Chemosensors202311738310.3390/chemosensors11070383
     [Google Scholar]
  69. HasanM.R. SharmaP. KhanS. Mushtaq NaikooU. BhallaK. AbdinM.Z. MalhotraN. AminabhaviT.M. ShettiN.P. NarangJ. Dengue-virosensor: Advancement of dengue virus-based biosensors.Sens. Diagn.20254172310.1039/D4SD00262H
     [Google Scholar]
  70. DianaBN YennyCB CarolinaMB EstebanT EmiroB Fluid management in dengue critical phase: Which, when, how much.Int. Arch. Med. Microbiol.202241015
     [Google Scholar]
  71. KularatneS.A. DalugamaC. Dengue infection: Global importance, immunopathology and management.Clin. Med.202222191310.7861/clinmed.2021‑0791 35078789
     [Google Scholar]
  72. FengF MaY QinP ZhaoY LiuZ WangW ChengB Temperature-driven dengue transmission in a changing climate: Patterns, trends, and future projections.Geohealth2024810e2024GH001059
     [Google Scholar]
  73. WangX. XuJ. ZhouY. Applications of geographic information systems in mosquito monitoring.J. Mosq. Res.20241416117110.5376/jmr.2024.14.0016
     [Google Scholar]
  74. PittonS. A New Strategy for Mosquito Biocontrol Based on the Improvement of Bacillus thuringiensis Effectiveness; Ph.D. Thesis, University of Milan (Università degli Studi di Milano), Department of Biosciences,2024Available from: https://hdl.handle.net/2434/1055108
  75. PorterJ. SullivanW. The cellular lives of Wolbachia.Nat. Rev. Microbiol.2023211175076610.1038/s41579‑023‑00918‑x 37430172
     [Google Scholar]
  76. RatcliffeN.A. Furtado PachecoJ.P. DysonP. CastroH.C. GonzalezM.S. AzambujaP. MelloC.B. Overview of paratransgenesis as a strategy to control pathogen transmission by insect vectors.Parasit. Vectors202215111210.1186/s13071‑021‑05132‑3 35361286
     [Google Scholar]
  77. BenedictM.Q. Sterile insect technique: Lessons from the past.J. Med. Entomol.20215851974197910.1093/jme/tjab024 33629719
     [Google Scholar]
  78. AkterT. BegumS. AkterT. Predatory competence of Danio rerio (Cypriniformes: Cyprinidae) and Poecilia reticulata (Cyprinodontiformes: Poeciliidae) as biocontrol agent of Aedes larvae (Diptera: Culicidae) under the laboratory condition.Bangl. J. Zool.2024513315327
     [Google Scholar]
  79. RasoolS. SaleemU. MahmoodS. AliM.Y. AbbasG. AhmadB. Prevention and treatment of dengue with natural drugs.Pak. J. Pharm. Sci.2011245153
     [Google Scholar]
  80. ChojnackaK. SkrzypczakD. IzydorczykG. MikulaK. SzopaD. Witek-KrowiakA. Antiviral properties of polyphenols from plants.Foods20211010227710.3390/foods10102277 34681326
     [Google Scholar]
  81. ShoyshobT.Z. HeyaI.A. AfrinN. EnniM.A. AshaI.J. MoniA. HannanM.A. UddinM.J. Protective mechanisms of carica papaya leaf extract and its bioactive compounds against dengue: Insights and prospects.Immuno.20244462964510.3390/immuno4040037
     [Google Scholar]
  82. HossainN. KumarP. YeongS.W. Dengue and drawbacks of marketed Carica papaya leaves supplements.Int. J. Green Pharm.201610S72S81 https://www.researchgate.net/publication/300053541_Dengue_and_drawbacks_of_marketed_Carica_papaya_leaves_supplements
    [Google Scholar]
  83. ChavdaV.P. KumarA. BanerjeeR. DasN. Ayurvedic and other herbal remedies for dengue: An update.Clin. Complement. Med. Pharmacol.20222310002410.1016/j.ccmp.2022.100024
     [Google Scholar]
  84. AnwarS. AhmedB. QadirM.I. Arboviruses: Transmission and host resistance.Crit. Rev. Eukaryot. Gene Expr.2024342153110.1615/critreveukaryotgeneexpr.2023049820
     [Google Scholar]
  85. KapteinS.J.F. NeytsJ. Towards antiviral therapies for treating dengue virus infections.Curr. Opin. Pharmacol.2016301710.1016/j.coph.2016.06.002 27367615
     [Google Scholar]
  86. dos Santos NascimentoI.J. de AquinoT.M. da Silva-JúniorE.F. Drug repurposing: A strategy for discovering inhibitors against emerging viral infections.Curr. Med. Chem.202128152887294210.2174/1875533XMTA5rMDYp5 32787752
     [Google Scholar]
  87. OoiE.E. Repurposing ivermectin as an anti-dengue drug.Clin. Infect. Dis.20217210e594e59510.1093/cid/ciaa1341 33124646
     [Google Scholar]
  88. ChanK.R. OngE.Z. OoiE.E. Therapeutic antibodies as a treatment option for dengue fever.Expert Rev. Anti Infect. Ther.201311111147115710.1586/14787210.2013.839941 24093625
     [Google Scholar]
  89. IdrisF. TingD.H.R. AlonsoS. An update on dengue vaccine development, challenges, and future perspectives.Expert Opin. Drug Discov.2021161475810.1080/17460441.2020.1811675 32838577
     [Google Scholar]
  90. Pintado SilvaJ. Fernandez-SesmaA. Challenges on the development of a dengue vaccine: A comprehensive review of the state of the art.J. Gen. Virol.2023104300183110.1099/jgv.0.001831 36857199
     [Google Scholar]
  91. TullyD. GriffithsC.L. Dengvaxia: The world’s first vaccine for prevention of secondary dengue.Ther. Adv. Vaccines Immunother.202192515135521101583910.1177/25151355211015839 34036241
     [Google Scholar]
  92. TraviesoT. LiJ. MaheshS. MelloJ.D.F.R.E. BlasiM. The use of viral vectors in vaccine development.NPJ Vaccines2022717510.1038/s41541‑022‑00503‑y 35787629
     [Google Scholar]
  93. DunguB. DonadeuM. Viral Vaccines. In Veterinary Vaccines: Principles and Applications. MetwallyS. El IdrissiA. ViljoenG. Hoboken, NJJohn Wiley & Sons Ltd.2021496110.1002/9781119506287.ch5
     [Google Scholar]
  94. NataliE.N. HorstA. MeierP. GreiffV. NuvoloneM. BabrakL.M. FinkK. MihoE. The dengue-specific immune response and antibody identification with machine learning. npj.Vaccines2024911610.1038/s41541‑023‑00788‑7
     [Google Scholar]
/content/journals/aia/10.2174/0122113525366277250306072415
Loading
Dengue Fever: A Comprehensive Review of Diagnosis and Management
Anti Infect. Agents 24, E22113525366277 (2026); https://doi.org/10.2174/0122113525366277250306072415
/content/journals/aia/10.2174/0122113525366277250306072415
/content/journals/aia/10.2174/0122113525366277250306072415
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Aedes mosquitoes; antiviral therapies; dengue fever; Serotypes; vaccine development; viral infection

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test